drugset
drugset / Trial / NCT00195910

Safety and Efficacy Study of Hydromorphone and Morphine

NCT00195910 ↗

Phase 2 Completed 198 enrolled Montefiore Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare a standard weight-based dose of intravenous (IV) hydromorphone (Dilaudid) to a standard weight-based dose of IV morphine in adults presenting to the Emergency Department (ED) with acute severe pain.

Timeline

Start
2004-10
Primary completion
2005-01
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified 0.015 mg/kg Intravenous
Comparator Morphine Other / unclassified 0.1 mg/kg Intravenous

Indications

No indication recorded.